DENTSPLY SIRONA (XRAY) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

XRAY Stock Forecast


DENTSPLY SIRONA stock forecast is as follows: an average price target of $40.00 (represents a 116.68% upside from XRAY’s last price of $18.46) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.

XRAY Price Target


The average price target for DENTSPLY SIRONA (XRAY) is $40.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $52.00 to $28.00. This represents a potential 116.68% upside from XRAY's last price of $18.46.

XRAY Analyst Ratings


Hold

According to 5 Wall Street analysts, DENTSPLY SIRONA's rating consensus is 'Hold'. The analyst rating breakdown for XRAY stock is 0 'Strong Buy' (0.00%), 2 'Buy' (40.00%), 3 'Hold' (60.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

DENTSPLY SIRONA Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 22, 2024Jeff JohnsonRobert W. Baird$31.00$26.3617.60%67.93%
Jul 18, 2024Jonathan BlockStifel Nicolaus$28.00$27.541.67%51.68%
May 03, 2024Jason BednarPiper Sandler$32.00$28.1313.76%73.35%
Nov 16, 2023David SaxonNeedham$35.00$29.6118.18%89.60%
Jun 01, 2022Kevin CaliendoUBS$47.00$39.0420.39%154.60%
Apr 22, 2022-H.C. Wainwright$48.00$42.0914.04%160.02%
Apr 21, 2022-Goldman Sachs$47.00$42.899.58%154.60%
Apr 20, 2022-Morgan Stanley$52.00$42.8921.24%181.69%
Apr 20, 2022-Piper Sandler$46.00$42.209.00%149.19%
Apr 19, 2022Jeffrey JohnsonRobert W. Baird$48.00$42.6312.60%160.02%
Row per page
Go to

The latest DENTSPLY SIRONA stock forecast, released on Jul 22, 2024 by Jeff Johnson from Robert W. Baird, set a price target of $31.00, which represents a 17.60% increase from the stock price at the time of the forecast ($26.36), and a 67.93% increase from XRAY last price ($18.46).

DENTSPLY SIRONA Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$30.33
Last Closing Price$18.46$18.46$18.46
Upside/Downside-100.00%-100.00%64.30%

In the current month, the average price target of DENTSPLY SIRONA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DENTSPLY SIRONA's last price of $18.46. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 08, 2024Evercore ISIUnderperformUnderperformHold
Sep 27, 2024Piper SandlerNeutralNeutralHold
Sep 20, 2024NeedhamBuyBuyHold
Aug 20, 2024NeedhamBuyBuyHold
Aug 20, 2024Evercore PartnersUnderperformUnderperformHold
Jul 18, 2024Piper SandlerBuyBuyHold
Jul 18, 2024NeedhamUnderperformUnderperformHold
Jun 25, 2024Piper SandlerBuyBuyHold
May 06, 2024Piper SandlerBuyBuyHold
May 03, 2024Piper SandlerNeutralNeutralHold
Row per page
Go to

DENTSPLY SIRONA's last stock rating was published by Evercore ISI on Oct 08, 2024. The company gave XRAY a "Underperform" rating, the same as its previous rate.

DENTSPLY SIRONA Financial Forecast


DENTSPLY SIRONA Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-----------------$947.00M$1.03B$978.00M$983.00M$947.00M$1.02B$965.00M$1.09B$1.07B$1.07B$1.03B$1.08B$894.80M
Avg Forecast$978.32M$976.19M$974.06M$971.94M$1.00B$966.35M$1.01B$962.89M$953.83M$926.50M$966.22M$921.49M$929.99M$939.10M$993.61M$969.45M$971.51M$975.21M$998.98M$937.70M$941.92M$1.01B$1.01B$991.01M$1.13B$1.03B$1.01B$947.57M$997.38M$839.02M
High Forecast$1.03B$1.03B$1.02B$1.02B$1.05B$1.01B$1.06B$1.01B$1.00B$972.86M$1.01B$967.74M$1.00B$939.87M$993.61M$969.45M$994.25M$975.31M$1.05B$984.62M$989.05M$1.01B$1.01B$991.01M$1.13B$1.03B$1.01B$947.57M$997.38M$839.02M
Low Forecast$954.41M$952.33M$950.26M$948.19M$979.27M$942.74M$984.67M$939.36M$930.52M$903.86M$942.61M$896.64M$898.32M$938.32M$993.61M$969.45M$951.41M$975.12M$974.56M$914.78M$918.90M$1.01B$1.01B$991.01M$1.13B$1.03B$1.01B$947.57M$997.38M$839.02M
# Analysts63333345452710999109998888999999
Surprise %-----------------0.97%1.03%1.04%1.04%0.94%1.01%0.97%0.96%1.04%1.05%1.08%1.09%1.07%

DENTSPLY SIRONA's average Quarter revenue forecast for Dec 23 based on 10 analysts is $971.51M, with a low forecast of $951.41M, and a high forecast of $994.25M. XRAY's average Quarter revenue forecast represents a 2.59% increase compared to the company's last Quarter revenue of $947.00M (Sep 23).

DENTSPLY SIRONA EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452710999109998888999999
EBITDA-----------------$77.00M$158.00M$138.00M$34.00M$142.00M$197.00M$182.00M$235.00M$239.00M$243.00M$254.00M$226.90M$188.00M
Avg Forecast$76.40M$76.23M$76.07M$75.90M$78.39M$75.46M$78.82M$75.19M$74.49M$72.35M$75.45M$71.96M$72.62M$73.34M$77.59M$207.93M$75.87M$76.16M$78.01M$189.02M$268.32M$202.46M$203.27M$171.84M$226.80M$205.94M$203.37M$179.29M$200.35M$168.54M
High Forecast$80.22M$80.05M$79.87M$79.70M$82.31M$79.24M$82.76M$78.96M$78.21M$75.97M$79.23M$75.57M$78.15M$73.40M$77.59M$249.51M$77.64M$76.16M$81.91M$226.83M$321.98M$202.46M$203.27M$206.21M$226.80M$205.94M$203.37M$215.14M$200.35M$168.54M
Low Forecast$74.53M$74.37M$74.21M$74.05M$76.47M$73.62M$76.89M$73.36M$72.67M$70.58M$73.61M$70.02M$70.15M$73.27M$77.59M$166.34M$74.30M$76.15M$76.10M$151.22M$214.65M$202.46M$203.27M$137.47M$226.80M$205.94M$203.37M$143.43M$200.35M$168.54M
Surprise %-----------------1.01%2.03%0.73%0.13%0.70%0.97%1.06%1.04%1.16%1.19%1.42%1.13%1.12%

10 analysts predict XRAY's average Quarter EBITDA for Dec 23 to be $75.87M, with a high of $77.64M and a low of $74.30M. This is -1.47% lower than DENTSPLY SIRONA's previous annual EBITDA (Sep 23) of $77.00M.

DENTSPLY SIRONA Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452710999109998888999999
Net Income-----------------$-266.00M$86.00M$-23.00M$-15.00M$-1.08B$73.00M$65.00M$102.00M$103.00M$99.00M$117.00M$98.50M$53.80M
Avg Forecast$115.92M$94.43M$99.11M$86.87M$124.32M$116.71M$121.09M$101.77M$108.04M$100.24M$101.56M$86.47M$89.93M$95.36M$99.76M$75.50M$87.04M$97.25M$86.80M$68.64M$116.46M$107.40M$112.72M$62.40M$161.99M$133.50M$136.62M$83.57M$131.88M$65.09M
High Forecast$123.46M$100.57M$105.56M$92.52M$132.41M$124.30M$128.97M$108.39M$115.07M$106.76M$108.17M$100.55M$120.55M$95.62M$99.79M$90.60M$93.11M$97.27M$92.45M$82.37M$139.75M$107.40M$112.72M$74.88M$161.99M$133.50M$136.62M$100.29M$131.88M$65.09M
Low Forecast$112.24M$91.43M$95.96M$84.11M$120.37M$113.00M$117.24M$98.53M$104.61M$97.05M$98.34M$76.42M$78.45M$95.10M$99.73M$60.40M$85.01M$97.24M$84.04M$54.91M$93.17M$107.40M$112.72M$49.92M$161.99M$133.50M$136.62M$66.86M$131.88M$65.09M
Surprise %------------------2.74%0.99%-0.34%-0.13%-10.03%0.65%1.04%0.63%0.77%0.72%1.40%0.75%0.83%

DENTSPLY SIRONA's average Quarter net income forecast for Sep 23 is $97.25M, with a range of $97.24M to $97.27M. XRAY's average Quarter net income forecast represents a 13.09% increase compared to the company's last Quarter net income of $86.00M (Jun 23).

DENTSPLY SIRONA SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452710999109998888999999
SG&A-----------------$372.00M$416.00M$416.00M$402.00M$401.00M$410.00M$374.00M$374.00M$394.00M$398.00M$385.00M$420.50M$341.90M
Avg Forecast$398.32M$397.45M$396.58M$395.72M$408.69M$393.44M$410.94M$392.04M$388.35M$377.22M$393.39M$375.18M$378.64M$382.35M$404.54M$434.44M$395.54M$397.05M$406.73M$394.94M$427.02M$409.84M$411.47M$359.04M$459.11M$416.89M$411.67M$275.00M$405.57M$341.18M
High Forecast$418.25M$417.34M$416.43M$415.52M$429.14M$413.13M$431.51M$411.65M$407.78M$396.09M$413.07M$394.01M$407.47M$382.66M$404.54M$521.33M$404.80M$397.09M$427.08M$473.93M$512.43M$409.84M$411.47M$430.85M$459.11M$416.89M$411.67M$330.00M$405.57M$341.18M
Low Forecast$388.58M$387.74M$386.89M$386.05M$398.70M$383.83M$400.90M$382.45M$378.86M$368.00M$383.78M$365.06M$365.75M$382.03M$404.54M$347.55M$387.36M$397.01M$396.79M$315.96M$341.62M$409.84M$411.47M$287.23M$459.11M$416.89M$411.67M$220.00M$405.57M$341.18M
Surprise %-----------------0.94%1.02%1.05%0.94%0.98%1.00%1.04%0.81%0.95%0.97%1.40%1.04%1.00%

DENTSPLY SIRONA's average Quarter SG&A projection for Dec 23 is $395.54M, based on 10 Wall Street analysts, with a range of $387.36M to $404.80M. The forecast indicates a 6.33% rise compared to XRAY last annual SG&A of $372.00M (Sep 23).

DENTSPLY SIRONA EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452710999109998888999999
EPS-----------------$-1.26$0.41$-0.11$-0.07$-5.01$0.34$0.32$0.47$0.47$0.45$0.53$0.45$0.25
Avg Forecast$0.58$0.47$0.49$0.43$0.62$0.58$0.60$0.51$0.54$0.50$0.51$0.43$0.45$0.47$0.50$0.42$0.43$0.48$0.43$0.34$0.33$0.52$0.55$0.56$0.79$0.65$0.66$0.57$0.64$0.32
High Forecast$0.61$0.50$0.53$0.46$0.66$0.62$0.64$0.54$0.57$0.53$0.54$0.50$0.60$0.48$0.50$0.42$0.46$0.48$0.46$0.36$0.35$0.52$0.55$0.56$0.79$0.65$0.66$0.57$0.64$0.32
Low Forecast$0.56$0.45$0.48$0.42$0.60$0.56$0.58$0.49$0.52$0.48$0.49$0.38$0.39$0.47$0.50$0.42$0.42$0.48$0.42$0.33$0.32$0.52$0.55$0.56$0.79$0.65$0.66$0.57$0.64$0.32
Surprise %------------------2.60%0.95%-0.32%-0.21%-9.59%0.62%0.57%0.60%0.72%0.68%0.93%0.70%0.79%

According to 9 Wall Street analysts, DENTSPLY SIRONA's projected average Quarter EPS for Sep 23 is $0.48, with a low estimate of $0.48 and a high estimate of $0.48. This represents a 18.01% increase compared to XRAY previous annual EPS of $0.41 (Jun 23).

DENTSPLY SIRONA Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
COOCooper Companies$99.48$298.00199.56%Buy
ANGOAngioDynamics$6.88$15.00118.02%Buy
XRAYDENTSPLY SIRONA$18.46$40.00116.68%Hold
TFXTeleflex$194.43$304.3656.54%Buy
BDXBecton, Dickinson and Company$224.10$283.2726.40%Buy
HAEHaemonetics$88.17$108.2522.77%Buy
WSTWest Pharmaceutical Services$307.21$345.3312.41%Buy
ALCAlcon$85.81$93.899.42%Buy
HOLXHologic$78.79$80.211.80%Buy
ICUIICU Medical$169.98$172.001.19%Buy
MMSIMerit Medical Systems$103.94$100.78-3.04%Buy
RMDResMed$239.42$219.13-8.47%Hold

XRAY Forecast FAQ


Is DENTSPLY SIRONA a good buy?

No, according to 5 Wall Street analysts, DENTSPLY SIRONA (XRAY) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 40.00% of XRAY's total ratings.

What is XRAY's price target?

DENTSPLY SIRONA (XRAY) average price target is $40 with a range of $28 to $52, implying a 116.68% from its last price of $18.46. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will DENTSPLY SIRONA stock go up soon?

According to Wall Street analysts' prediction for XRAY stock, the company can go up by 116.68% (from the last price of $18.46 to the average price target of $40), up by 181.69% based on the highest stock price target, and up by 51.68% based on the lowest stock price target.

Can DENTSPLY SIRONA stock reach $30?

XRAY's average twelve months analyst stock price target of $40 supports the claim that DENTSPLY SIRONA can reach $30 in the near future.

What are DENTSPLY SIRONA's analysts' financial forecasts?

DENTSPLY SIRONA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.94B (high $4.14B, low $3.85B), average EBITDA is $307.87M (high $323.27M, low $300.34M), average net income is $463.89M (high $494.06M, low $449.15M), average SG&A $1.61B (high $1.69B, low $1.57B), and average EPS is $2.31 (high $2.46, low $2.23). XRAY's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $3.9B (high $4.1B, low $3.81B), average EBITDA is $304.6M (high $319.84M, low $297.15M), average net income is $396.34M (high $422.12M, low $383.75M), average SG&A $1.59B (high $1.67B, low $1.55B), and average EPS is $1.97 (high $2.1, low $1.91).

Did the XRAY's actual financial results beat the analysts' financial forecasts?

Based on DENTSPLY SIRONA's last annual report (Dec 2022), the company's revenue was $3.92B, which missed the average analysts forecast of $3.95B by -0.78%. Apple's EBITDA was $634M, missing the average prediction of $845.88M by -25.05%. The company's net income was $-950M, missing the average estimation of $398.98M by -338.10%. Apple's SG&A was $1.59B, missing the average forecast of $1.61B by -1.14%. Lastly, the company's EPS was $-4.41, missing the average prediction of $1.96 by -325.24%. In terms of the last quarterly report (Sep 2023), DENTSPLY SIRONA's revenue was $947M, missing the average analysts' forecast of $975.21M by -2.89%. The company's EBITDA was $77M, beating the average prediction of $76.16M by 1.11%. DENTSPLY SIRONA's net income was $-266M, missing the average estimation of $97.25M by -373.51%. The company's SG&A was $372M, missing the average forecast of $397.05M by -6.31%. Lastly, the company's EPS was $-1.26, missing the average prediction of $0.484 by -360.41%